Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1866 1
1927 1
1931 1
1945 1
1965 1
1966 2
1967 1
1969 3
1970 2
1971 2
1972 1
1973 1
1974 1
1975 2
1976 1
1977 2
1978 1
1979 3
1980 9
1981 5
1982 3
1983 6
1984 8
1985 6
1986 13
1987 17
1988 17
1989 31
1990 18
1991 19
1992 21
1993 21
1994 29
1995 24
1996 18
1997 17
1998 14
1999 4
2000 6
2001 6
2002 10
2003 7
2004 6
2005 11
2006 5
2007 8
2008 10
2009 14
2010 25
2011 20
2012 15
2013 13
2014 8
2015 6
2016 9
2017 7
2018 9
2019 4
2020 5
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 8915969

507 results
Results by year
Filters applied: . Clear all
Page 1
Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.
Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME. Klahr S, et al. J Am Soc Nephrol. 1995 Jun;5(12):2037-47. J Am Soc Nephrol. 1995. PMID: 7579052 Free article. Clinical Trial.
The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.
Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. Klahr S, et al. N Engl J Med. 1994 Mar 31;330(13):877-84. doi: 10.1056/NEJM199403313301301. N Engl J Med. 1994. PMID: 8114857 Free article. Clinical Trial.
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T. Rahman M, et al. Arch Intern Med. 2005 Apr 25;165(8):936-46. doi: 10.1001/archinte.165.8.936. Arch Intern Med. 2005. PMID: 15851647 Clinical Trial.
The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group. Esnault VL, et al. Clin Ther. 2008 Mar;30(3):482-98. doi: 10.1016/j.clinthera.2008.03.006. Clin Ther. 2008. PMID: 18405787 Clinical Trial.
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand SG, Miller E, Smith W, Bakris GL. Lea J, et al. Arch Intern Med. 2005 Apr 25;165(8):947-53. doi: 10.1001/archinte.165.8.947. Arch Intern Med. 2005. PMID: 15851648 Clinical Trial.
Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study.
Teschan PE, Beck GJ, Dwyer JT, Greene T, Klahr S, Levy AS, Mitch WE, Snetselaar LG, Steinman TI, Walser M. Teschan PE, et al. Clin Nephrol. 1998 Nov;50(5):273-83. Clin Nephrol. 1998. PMID: 9840314 Clinical Trial.
507 results
Jump to page
Feedback